Alloxan acts as a prooxidant only under reducing conditions: Influence of melatonin

Cellular and Molecular Life Sciences

Volumn 55, Issue 3, 1999, Pages 487-493

  Bromme H J ^a   Ebelt, H ^a   Peschke, D ^a   Peschke, E ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Alloxan; Antioxidant; Diabetes; Free radicals; Lucigenin; Melatonin; NBT; Oxidative stress; Prooxidant

Indexed keywords

ALLOXAN; ANTIOXIDANT; CATALASE; CYSTEINE; DIALURIC ACID; FORMAZAN; GLUTATHIONE; HYDROGEN PEROXIDE; LUCIGENIN; MELATONIN; NITROBLUE TETRAZOLIUM; OXIDIZING AGENT; OXYGEN; SCAVENGER; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; NITROBLUE TETRAZOLIUM TEST; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; REDUCTION;

ALLOXAN; ANIMALS; ANTIOXIDANTS; CHEMILUMINESCENT MEASUREMENTS; COLORIMETRY; FREE RADICAL SCAVENGERS; GLUTATHIONE; HYDROGEN PEROXIDE; IMIDAZOLES; ISLETS OF LANGERHANS; MELATONIN; NITROBLUE TETRAZOLIUM; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 0032922770     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050305     Document Type: Article

References (33)

1. Zhang H., Gao G. and Brunk U. T. (1992) Extracellular reduction of alloxan results in oxygen radical-mediated attack on plasma and lysosomal membranes. APMIS 100: 317-325
2. Heim K. F., Thomas G. and Ramwell P. W. (1991) Superoxide production in the isolated aorta and the effect of alloxan, indomethacin and nitrovasodilators. J. Pharmacol. Exp. Therap. 256: 537-541
3. Winterbourn C. C., Cowden W. B. and Sutton H. C. (1989) Auto-oxidation of dialuric acid, divicine and isouramil. Superoxide dependent and independent mechanism. Biochem. Pharmacol. 38: 611-618
4. Sakurai K. and Miura T. (1989) Generation of free radicals by alloxan in the presence of bovine serum albumin: a role of sulfhydryl groups in alloxan cytotoxicity. Biochem. Int. 19: 405-412
5. Munday R. (1988) Dialuric acid autoxidation. Effect of transition metals on the reaction rate and on the generation of 'active oxygen' species. Biochem. Pharmacol. 37: 409-413
6. Asayama K., English D., Slonim A. E. and Burr I. M. (1984) Chemiluminescence as an index of drug-induced free radical production in pancreatic islets. Diabetes 33: 160-163
7. Lenzen S. and Munday R. (1991) Thiol-group reactivity, hydrophilicity and stability of alloxan, its reduction products and its N-methyl derivatives and a comparison with ninhydrin. Biochem. Pharmacol. 42: 1385-1391
8. Lenzen S. and Panten U. (1988) Alloxan: history and mechanism of action. Diabetologia 31: 337-342
9. Kawada J. (1992) New hypotheses for the mechanism of streptozotocin and alloxan inducing diabetes mellitus. Yakugaku Zasshi 112: 773-791
10. Nukatsuka M., Sakurai H. and Kawada J. (1989) Generation of alloxan free radicals in chemical and biological systems: implication in the diabetogenic action of alloxan. Biochem. Biophys. Res. Comm. 165: 278-283
11. Nukatsuka M., Sakurai H. and Kawada J. (1989) Microsomal reduction of alloxan produces alloxan anion radicals. Naturwissenschaften 76: 574-575
12. Poeggeler B., Reiter R. J., Tan D. X., Chen L. D. and Manchester L. C. (1993) Melatonin, hydroxyl radical-mediated oxidative damage and aging: a hypothesis. J. Pineal. Res. 4: 151-168
13. Reiter R. J. (1997) Antioxidant actions of melatonin. Adv. Pharmacol. 38: 103-117
14. Reiter R. J., Carneiro R. C. and Oh C. S. (1997) Melatonin in relation to cellular antioxidative defence mechanisms. Horm. Metab. Res. 29: 363-372
15. Marshall K. A., Reiter R. J., Poeggeler B., Arouma O. I. and Halliwell B. (1996) Evaluation of the anti-oxidant activity of melatonin in vitro. Free Radical Biol. Med. 21: 307-315
16. John M. (1980) The NBT test - a review. Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. 107: 358-371
17. Elferink J. G. (1984) Measurement of the metabolic burst in human neutrophiles: a comparison between cytochrome c and NBT reduction. Res. Comm. Chem. Pathol. Pharmacol. 43: 339-342
18. Shimuzu M., Morita S., Yamano T. and Yamada A. (1989) Relationship between hepatic glutathione content and carbon tetrachloride-induced hepatotoxicity in vivo. Toxicol. Lett. 47: 95-102
19. Patterson J. W., Lazarow A. and Levey S. (1949) Alloxan and dialuric acid: their stabilities and ultraviolet absorption spectra. J. Biol. Chem. 177: 187-196
20. Frerichs H. and W. Creutzfeldt W. (1971) Der experimentelle chemische Diabetes In: Handbuch der experimentellen Pharmakologie, vol. 32/1 Insulin 1, pp. 159-202, Dörzbach H. (ed.), Springer, Berlin
21. Miwa I. and Okuda J. (1982) Non-enzymatic reduction of alloxan by reduced nicotinamide nucleotide. Biochem. Pharmacol. 31: 921-925
22. Munday R., Ludwig K. and Lenzen S. (1993) The relation between physicochemical properties and the biological effects of alloxan and several N-alkyl substituted alloxan derivatives. J. Endocrinol. 139: 153-163
23. Mohazzab K. M. and Wolin M. S. (1994) Sites of superoxide anion production detected by lucigenin in calf pulmonaryartery smooth muscle. Am. J. Physiol. 267: L815-L822
24. Gyllenhammar H. (1987) Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J. Immunol. Meth. 97: 209-213
25. -. Free Radical Biol. Med. 15: 447-451
26. Winterbourn C. C. and Munday R. (1989) Glutathione-mediated redox cycling of alloxan. Mechanism of SOD inhibition and metal-catalyzed OH * formation. Biochem. Pharmacol. 38: 271-277
27. Bijsterbosch M. K., Duursma A. M., Bouma J. M. W. and Gruber M. (1981) The plasma volume of the Wistar rat in relation to the body weight. Experientia 37: 381-382
28. Gorus F. K., Malaisse W. J. and Pipeleers D. G. (1982) Selective uptake of alloxan by pancreatic B-cells. Biochem. J. 208: 313-315
29. Malaisse W. J., Malaisse-Lagae F., Sener A. and Pipeleers D. G. (1982) Determinants of the selective toxicity of alloxan to the pancreatic B cell. Proc. Natl. Acad. Sci. USA 79: 927-930
30. Tiedge M., Lortz S., Drinkgern J. and Lenzen S. (1997) Relation between antioxidant enzyme gene expression and antioxidative defence status of insulin-producing cells. Diabetes 46: 1733-1742
31. Milcu S. M., Nanu-Ionescu L. and Milcu I. (1971) The effect of pinealectomy on plasma insulin in rats. In: The pineal gland. A Ciba Foundation Symposium, pp. 345-357, Wolstenholme G. E. W. and Knight J. (eds), Churchill Livingstone, Edinburgh
32. Brömme H.-J., Ebelt H., Mörke W., Peschke D. and Peschke E. (1999) Interpretationsansätze radikalinduzierter Schädigungen durch Alloxan an der pankreatischen B-Zelle in vitro - Einfluß von Melatonin. Verh. Anat. Ges. 181 (Suppl.), in press
33. Ebelt H., Peschke D., Blume R., Meinel P. and Peschke E. (1998) Radikal-induzierte Veränderungen an pankrealischen B-Zellen der Wistar-Ratte in vitro Einfluß von Melatonin. Verh. Anat. Ges. 180 (Suppl.): 99